Research, News & Discoveries

Vanderbilt biomedical graduate students and postdocs attended ASPIRE on the Road 2025 in San Diego, California. Over three days, they explored Southern California's biotech and pharmaceutical scene, connecting with alums, industry leaders, and innovative companies. Read More

What makes these results exceptional isn’t just the compounds themselves, it’s what they represent: the value of translational research grounded in real-world therapeutic goals. The partners chose to release these best-in-class tool compounds to the scientific community to accelerate further discovery. Read More

Venkatesh is recognized for educational leadership in curriculum design, implementation and evaluation, as well as grant-funded initiatives and scholarly work including publications and presentations. Read More

Meet Tracy O’Brien, an administrative assistant in the Office of the Dean of the Vanderbilt University School of Medicine Basic Sciences. Read More

Fingleton has served at the helm of the  Interdisciplinary Graduate Program since 2021, weathering post-COVID-19 recruitment trends, the first-ever IGP curriculum redesign, and the current federal funding uncertainties. Read More

Kaitlyn Browning, PhD’24, sat down with us to discuss her experience studying basic science at Vanderbilt and how it played a role in her career. Browning is now a scientific program analyst for the National Institutes of Health. Read More

In this episode of Quantum Potential, Craig Lindsley, William K. Warren, Jr. Professor of Medicine, University Distinguished Professor of Biochemistry, Chemistry and Pharmacology and executive director of the Warren Center for Neuroscience Drug Discovery, joins Provost C. Cybele Raver to discuss transformative research exploring how subtle tweaks to brain chemistry could change the way we treat neurodegenerative diseases and chronic pain. Lindsley shares how academic-industry collaborations drive innovation in drug discovery and highlights how Vanderbilt’s scientific workflow is enabling the broader research community to build on its breakthroughs. Read More

“Embrace the transformative power of education to illuminate pathways for others,” C. André Christie-Mizell, Centennial Professor of Sociology, Vice Provost for Graduate Education, and Dean of the Graduate School said. “Small acts and a kind word can change the direction of someone’s life.” Read More

BrightFocus Foundation’s Alzheimer’s Disease Research program has awarded a three-year, $300,000 research grant to Monica Santisteban, assistant professor of Medicine, Neurology and Pharmacology, to investigate the role of the renin angiotensin system in the progression of Alzheimer’s disease pathology. Read More

For the nearly 30 percent of major depressive disorder patients who are resistant to treatment, ketamine provides some amount of normalcy, but it requires frequent treatment and can have side effects. Vanderbilt researchers now show in proof-of-concept experiments that it may be possible to extend ketamine’s antidepressant effect from about a week to up to two months. Read More